Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/10826068.2020.1848869 http://scihub22266oqcxt.onion/10.1080/10826068.2020.1848869 33226885!ä!33226885 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Prep+Biochem+Biotechnol 2021 ; 51 (7): 650-658 Nephropedia Template TP {{tp|p=33226885|t=2021. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination |pdf=|usr=}}{{33226885}} gab.com Text An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination JO: Prep Biochem Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=33226885 #FOAvip The causative agent of novel coronavirus disease (COVID-19) is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 possesses RNA as a genetic material with 79% of the match with the bat SARS-CoV genome, which became epidemic in 2002. The SARS-CoV-2 peripheral Spike-Fc protein binds specifically to the ACE2 receptors present on bronchial epithelial cells and alveolar pneumocytes to downmodulates its expression which leads to severe acute respiratory failure. The disease is super infectious from human to human and the symptoms are similar to flu. The old aged and immunocompromised population are severely affected, and healthcare providers globally applied various strategies for treatment including the repurposing of drugs including antimalarial drug, hydroxychloroquine and anti-viral drugs.Herein, we described the SARS-CoV-2 pandemic, immune responses, possible drug targets, vaccines under the trials and correlated the possibility of trained immunity induced by BCG vaccination over control of SARS-CoV-2 infection. The countries with constraint BCG vaccination policy are struggling badly compared to countries with BCG vaccination policy. The BCG vaccination policy supports either lowering the total number of COVID-19 cases or the increasing recovery rate. Twit Text FOAVip An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination ????Prep Biochem Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=33226885 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33226885 #FOAvip English Wikipedia <ref>{{Cite pmid|33226885}}</ref> An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination #MMPMID33226885 Khade SM; Yabaji SM; Srivastava J Prep Biochem Biotechnol 2021[]; 51 (7): 650-658 PMID33226885show ga The causative agent of novel coronavirus disease (COVID-19) is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 possesses RNA as a genetic material with 79% of the match with the bat SARS-CoV genome, which became epidemic in 2002. The SARS-CoV-2 peripheral Spike-Fc protein binds specifically to the ACE2 receptors present on bronchial epithelial cells and alveolar pneumocytes to downmodulates its expression which leads to severe acute respiratory failure. The disease is super infectious from human to human and the symptoms are similar to flu. The old aged and immunocompromised population are severely affected, and healthcare providers globally applied various strategies for treatment including the repurposing of drugs including antimalarial drug, hydroxychloroquine and anti-viral drugs.Herein, we described the SARS-CoV-2 pandemic, immune responses, possible drug targets, vaccines under the trials and correlated the possibility of trained immunity induced by BCG vaccination over control of SARS-CoV-2 infection. The countries with constraint BCG vaccination policy are struggling badly compared to countries with BCG vaccination policy. The BCG vaccination policy supports either lowering the total number of COVID-19 cases or the increasing recovery rate. |Antiviral Agents/therapeutic use[MESH] |BCG Vaccine/immunology/*therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Vaccines/immunology/*therapeutic use[MESH] |COVID-19/epidemiology/mortality/*therapy[MESH] |Humans[MESH] |Mass Vaccination[MESH] |Mycobacterium bovis/immunology[MESH] |Pandemics[MESH]An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG(epmc).pdf DeepDyve Pubget Overpricing